299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02010411 (ClinicalTrials.gov) | June 2004 | 9/12/2013 | Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis | Effects of Prolastin Aerosol Therapy on Bacterial Density in the Airways of Patients With Cystic Fibrosis | Cystic Fibrosis | Drug: Prolastin (drug) | Université de Sherbrooke | NULL | Terminated | 14 Years | N/A | Both | 17 | Phase 2 | Canada |
2 | NCT00486837 (ClinicalTrials.gov) | December 2003 | 13/6/2007 | Deposition of Inhaled Prolastin in Cystic Fibrosis Patients | Multicenter, Randomized, Parallel Group Study to Investigate the Optimal Deposition Site for Inhaled Prolastin® in Patients With Cystic Fibrosis (CF) | Cystic Fibrosis | Drug: Alpha1-Proteinase Inhibitor (Human) | Grifols Therapeutics Inc. | NULL | Completed | 8 Years | N/A | All | 72 | Phase 2 | NULL |